DDInter947 DDInter75
Human interferon beta (166 residues), glycosylated, MW=22.5kD. It is produced by mammalian cells (Chinese Hamster Ovary cells) into which the human interferon beta gene has been introduced. The amino acid sequence is identical to that of natural human interferon beta.
An antitubercular agent often administered in association with isoniazid. The sodium salt of the drug is better tolerated than the free acid.
Interferon beta-1a {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Methyldopa
Methyldopa {u} (Compound) resembles {v} (Compound) Aminosalicylic acid
Interferon beta-1a {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Bortezomib
Bortezomib {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Levodopa
Levodopa {u} (Compound) resembles {v} (Compound) Aminosalicylic acid
Interferon beta-1a {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Methyldopa
Methyldopa {u} (Compound) resembles {v} (Compound) Levodopa
Levodopa {u} (Compound) resembles {v} (Compound) Aminosalicylic acid
Interferon beta-1a {u} may lead to a major life threatening interaction when taken with {v} Leflunomide
Leflunomide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Levodopa
Levodopa {u} (Compound) resembles {v} (Compound) Aminosalicylic acid
Interferon beta-1a {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Bortezomib
Bortezomib {u} (Compound) binds {v} (Gene) PTGS1
PTGS1 {u} (Gene) is bound by {v} (Compound) Aminosalicylic acid
Interferon beta-1a {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Methyldopa
Methyldopa {u} (Compound) resembles {v} (Compound) Droxidopa
Droxidopa {u} (Compound) resembles {v} (Compound) Aminosalicylic acid
Interferon beta-1a {u} may lead to a major life threatening interaction when taken with {v} Teriflunomide
Teriflunomide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Levodopa
Levodopa {u} (Compound) resembles {v} (Compound) Aminosalicylic acid
Interferon beta-1a {u} may lead to a major life threatening interaction when taken with {v} Leflunomide
Leflunomide {u} may lead to a major life threatening interaction when taken with {v} Diflunisal
Diflunisal {u} (Compound) resembles {v} (Compound) Aminosalicylic acid
Interferon beta-1a {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Bortezomib
Bortezomib {u} (Compound) downregulates {v} (Gene) PIP4K2B
PIP4K2B {u} (Gene) is upregulated by {v} (Compound) Aminosalicylic acid
Interferon beta-1a {u} may lead to a major life threatening interaction when taken with {v} Leflunomide
Leflunomide {u} may lead to a major life threatening interaction when taken with {v} Methyldopa
Methyldopa {u} (Compound) resembles {v} (Compound) Aminosalicylic acid
Interferon beta-1a may cause a moderate interaction that could exacerbate diseases when taken with Methyldopa and Methyldopa (Compound) resembles Aminosalicylic acid (Compound)
Interferon beta-1a may cause a moderate interaction that could exacerbate diseases when taken with Bortezomib and Bortezomib may cause a moderate interaction that could exacerbate diseases when taken with Levodopa and Levodopa (Compound) resembles Aminosalicylic acid (Compound)
Interferon beta-1a may cause a moderate interaction that could exacerbate diseases when taken with Methyldopa and Methyldopa (Compound) resembles Levodopa (Compound) and Levodopa (Compound) resembles Aminosalicylic acid (Compound)
Interferon beta-1a may lead to a major life threatening interaction when taken with Leflunomide and Leflunomide may cause a moderate interaction that could exacerbate diseases when taken with Levodopa and Levodopa (Compound) resembles Aminosalicylic acid (Compound)
Interferon beta-1a may cause a moderate interaction that could exacerbate diseases when taken with Bortezomib and Bortezomib (Compound) binds PTGS1 (Gene) and PTGS1 (Gene) is bound by Aminosalicylic acid (Compound)
Interferon beta-1a may cause a moderate interaction that could exacerbate diseases when taken with Methyldopa and Methyldopa (Compound) resembles Droxidopa (Compound) and Droxidopa (Compound) resembles Aminosalicylic acid (Compound)
Interferon beta-1a may lead to a major life threatening interaction when taken with Teriflunomide and Teriflunomide may cause a moderate interaction that could exacerbate diseases when taken with Levodopa and Levodopa (Compound) resembles Aminosalicylic acid (Compound)
Interferon beta-1a may lead to a major life threatening interaction when taken with Leflunomide and Leflunomide may lead to a major life threatening interaction when taken with Diflunisal and Diflunisal (Compound) resembles Aminosalicylic acid (Compound)
Interferon beta-1a may cause a moderate interaction that could exacerbate diseases when taken with Bortezomib and Bortezomib (Compound) downregulates PIP4K2B (Gene) and PIP4K2B (Gene) is upregulated by Aminosalicylic acid (Compound)
Interferon beta-1a may lead to a major life threatening interaction when taken with Leflunomide and Leflunomide may lead to a major life threatening interaction when taken with Methyldopa and Methyldopa (Compound) resembles Aminosalicylic acid (Compound)